z-logo
Premium
Does Medical Therapy Improve S ino N asal O utcomes T est–22 Domain Scores? An Analysis of Clinically Important Differences
Author(s) -
Chowdhury Naweed I.,
Mace Jess C.,
Bodner Todd E.,
Alt Jeremiah A.,
Deconde Adam S.,
Levy Joshua M.,
Smith Timothy L.
Publication year - 2019
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1002/lary.27470
Subject(s) - minimal clinically important difference , medicine , chronic rhinosinusitis , cohort , physical therapy , observational study , cohort study , randomized controlled trial
Objectives/Hypothesis Minimum clinically important differences (MCIDs) for the 22‐item SinoNasal Outcomes Test (SNOT‐22) in patients with chronic rhinosinusitis (CRS) electing endoscopic sinus surgery (ESS) are well described. However, similar estimations for the MCID have not been investigated for patients electing continued appropriate medical therapy (CAMT). We sought to determine MCID values for a medically treated CRS cohort and compare them to historical MCIDs associated with ESS. Study Design Prospective observational cohort study. Methods One hundred twenty patients with refractory CRS electing CAMT were prospectively enrolled from academic referral clinics into an observational cohort study. Baseline and posttreatment SNOT‐22 survey responses were collected. Four distribution‐based methods for calculating MCIDs (e.g., half‐standard deviation, Cohen's d , standard error of measurement, and minimum detectable change) were used to identify a range of MCID values for SNOT‐22 total and domain scores. Results The average MCID value for SNOT‐22 total scores was 8.0, whereas mean MCID values for rhinologic, extranasal rhinologic, ear/facial, psychological, and sleep symptom domain scores were 3.9, 2.5, 3.3, 3.4, and 2.9, respectively, comparable to previously reported values for patients electing ESS. Although change in SNOT‐22 total scores following CAMT exceeded the MCID, none of the average SNOT‐22 domain score improvements surpassed their respective MCID thresholds. Conclusions MCID values for SNOT‐22 total and domain scores in patients electing CAMT are similar to previously published MCID values associated with ESS, indicating that MCID values are independent of treatment modality selection. Therefore, despite evidence of statistical significance, CAMT for CRS may not be associated with clinically discernable improvements in average SNOT‐22 domain scores. Level of Evidence 2c Laryngoscope , 129:31–36, 2019

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom